TILT Biotherapeutics
Helsinki, Finland · Founded 2013 · $38.9M raised
- Headquarters
- Helsinki
- Employees
- 11–50
- Founded
- 2013
- Business Model
- B2B
- Website
- tiltbio.com
- Total Funding
- $38.9M
- Last Round
- $25.6M Series BMay 2025
- Rounds
- 3
About
Develops cancer immunotherapies using engineered oncolytic adenoviruses to enhance T-cell responses.
Summary
TILT Biotherapeutics is a Biotech company based in Helsinki, Finland, founded in 2013. It has raised $38.9M in total across 3 rounds, most recently a $25.6M Series B round in May 2025. Investors include Lifeline Ventures, European Innovation Council Fund and Tesi.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...